Morita A, Nishikawa K, Yamada F, Yamanaka K, et al. Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis. J Dermatol 2022 Jul 7. doi: 10.1111/1346-8138.16508.
PMID: 35799412